The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia-Reference-Cited by-同舟云学术

The intersection of genetic and chemical genomic screens identifies GSK-3α as a target in human acute myeloid leukemia

Published:2012-03-01 Issue:3 Volume:122 Page:935-947
ISSN:0021-9738
Container-title:Journal of Clinical Investigation
language:en
Short-container-title:J. Clin. Invest.

Author:

Banerji Versha,Frumm Stacey M.,Ross Kenneth N.,Li Loretta S.,Schinzel Anna C.,Hahn Cynthia K.,Kakoza Rose M.,Chow Kwan T.,Ross Linda,Alexe Gabriela,Tolliday Nicola,Inguilizian Haig,Galinsky Ilene,Stone Richard M.,DeAngelo Daniel J.,Roti Giovanni,Aster Jon C.,Hahn William C.,Kung Andrew L.,Stegmaier Kimberly

Publisher

American Society for Clinical Investigation

Subject

General Medicine

Reference48 articles.

1. Recent advances in the treatment of acute myeloid leukemia

2. Acute Myeloid Leukemia

3. Diagnosis and management of acute myeloid leukemia in adults: recommendations from an international expert panel, on behalf of the European LeukemiaNet

4. DNMT3AMutations in Acute Myeloid Leukemia

5. Recurring Mutations Found by Sequencing an Acute Myeloid Leukemia Genome

Cited by 100 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Natural compound screening predicts novel GSK-3 isoform-specific inhibitors;Biochimie;2024-10

2. Glycogen synthase kinase‐3β: A multifaceted player in ischemia‐reperfusion injury and its therapeutic prospects;Journal of Cellular Physiology;2024-07-04

3. Natural compound screening predicts novel GSK-3 isoform-specific inhibitors;2024-04-22

4. HDAC inhibitor derivatives induce differentiation of leukemic cells through two distinct and separable mechanisms;2024-01-07

5. Loss of GSK3β in hematopoietic stem cells results in normal hematopoiesis in mice;Blood Advances;2023-11-29